Browsing by Author "OAKNIN, ANA"
Now showing items 1-15 of 15
-
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials
Bareche, Yacine; Abbas-Aghababazadeh, Farnoosh; Lo Giacco, Deborah; Martin Casado, Agatha; Saavedra Gadea, Omar; Berche, Roger; Mirallas, Oriol; Jimenez, Jose; Valverde Morales, Claudia Maria; Díez García, Marc; Hernando-Calvo, Alberto; Vila-Casadesús, Maria; Gonzalez Medina, Alberto; Brana, Irene; Vieito , Maria; fasani, roberta; Mancuso, Francesco Mattia; Saoudi Gonzalez, Nadia; Suárez, Cristina; Elez, Elena; Capdevila Castillon, Jaume; OAKNIN, ANA; Saura Manich, Cristina; Macarulla, Teresa; Carles, Joan; FELIP, ENRIQUETA; Nuciforo, Paolo; Seoane, Joan; Tabernero, Josep; GARRALDA, Elena; Vivancos, Ana; MUÑOZ COUSELO, EVA; Dienstmann, Rodrigo (Elsevier, 2023-10-13) -
A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer
Tinker, Anna; Mathews, Cara; Press, Joshua; OAKNIN, ANA; Gilbert, Lucy; Brown, Jubilee (Future Medicine, 2023-08) -
A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer
Han, Sileny; Oza, Amit; Colombo, Nicoletta; Raspagliesi, Francesco; Wenham, Robert M.; OAKNIN, ANA (Elsevier, 2023-11) -
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial
André, Thierry; Berton, Dominique; Curigliano, Giuseppe; Sabatier, Renaud; Tinker, Anna; OAKNIN, ANA (American Medical Association, 2023-11) -
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial
Kurtz, Jean-Emmanuel; PUJADE-LAURAINE, Eric; Belin, Lisa; Leitner, Katharina; OAKNIN, ANA; Cibula, David (American Society of Clinical Oncology, 2023-10-20) -
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
Matulonis, Ursula; pignata, sandro; DEAN, ANDREW; denys, hannelore; Lorusso, Domenica; OAKNIN, ANA (American Society of Clinical Oncology, 2023-05-01) -
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023
Cibula, David; raspollini, maria rosaria; Planchamp, François; Centeno, Carlos; Chargari, Cyrus; Felix, Ana; OAKNIN, ANA (BMJ, 2023-05) -
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Lheureux, Stephanie; Prokopec, Stephenie; Oldfield, Leslie E.; Gonzalez-Ochoa, Eduardo; Bruce, Jeff; Wong, Derek; OAKNIN, ANA (American Association for Cancer Research, 2023-09-15) -
Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
ray coquard, isabelle; Lorusso, Domenica; OAKNIN, ANA; Cibula, David; Vergote, Ignace; Van Gorp, Toon (Taylor & Francis, 2023) -
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study
Moreno, Victor; Kristeleit, Rebecca; leary, alexandra; DELORD, Jean-Pierre; OAKNIN, ANA; Castellano, Daniel (Springer, 2023-10) -
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
Koppikar, Smruti; OAKNIN, ANA; Babu, K. Govind; Lorusso, Domenica; Gupta, S.; Wu, L.-Y. (Elsevier, 2023-02) -
Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours
leary, alexandra; Trigo, José Manuel; DELORD, Jean-Pierre; Boni, valentina; OAKNIN, ANA; Brana, Irene; Moreno, Victor (Elsevier, 2023-10) -
Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study
Colombo, Nicoletta; Van Gorp, Toon; Grisham, Rachel; Fleming, Gini; Matulonis, Ursula; OAKNIN, ANA (American Society of Clinical Oncology, 2023-10-20) -
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
Pothuri, Bhavana; Gilbert, Lucy; Brown, Jubilee; Ghamande, Sharad; OAKNIN, ANA; Sabatier, Renaud (American Association for Cancer Research, 2023-11-15) -
The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer—A GEICO Study
Fernandez-Serra, Antonio; López-Reig, Raquel; Márquez, Raúl; Gallego, Alejandro; De Sande-González, Luis Miguel; Yubero Esteban, Alfonso; OAKNIN, ANA (MDPI, 2023-06-01)